Impact of health legislation on the sale of anorectics in a city in the Amazon region

Detalhes bibliográficos
Autor(a) principal: Castro,Luana Valéria da Silva
Data de Publicação: 2012
Outros Autores: Farias Junior,Gilvo, Teixeira,Francisco Martins, Vieira,José Ricardo dos Santos, Maia,Cristiane do Socorro Ferraz
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Acta Amazonica
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0044-59672012000200005
Resumo: OBJECTIVES: The International Narcotics Control Board released its 2005 annual report, highlighting the Brazil population as one of the largest consumers of anorectics. In Brazil, the National Health Surveillance Agency issued the resolution RDC 58/2007 in order to control the prescription and sale of such drugs. In Belém, the biggest city in the Brazilian Amazon region, this resolution came into force in 2008, leading to inspections of drugstores and magistral pharmacies. The aim of this work was to evaluate the consumption of psychotropic anorectic drugs and the impact of RDC 58/2007 on the prescription and dispensing of anorectics in drugstores and magistral pharmacies in Belém. METHODOLOGY: A retrospective quantitative and descriptive study was conducted of records from the Municipal Department of Health Surveillance of Belém, for 2005 to 2008. The differences in findings were regarded significant when p < 0.05. RESULTS: A total of 1,641 balance sheets of drugstores and magistral pharmacies were analyzed. Amfepramone was the most dispensed medication, followed by fenproporex and mazindol. The highest consumption of anorectics occurred in magistral pharmacies. In 2008, there was a significant reduction in dispensing of anorectics, in drugstores as well as in magistral pharmacies. CONCLUSIONS: This study showed that there was a decrease in the dispensing of anorectics after RDC 58/2007 came into force, and that the magistral pharmacies dispensed more of these drugs. This resolution is a remarkable tool in health control, where it is of great benefit to public health and contributes substantially to the rational use of medicines in Brazil.
id INPA-3_f7f786d3c65abdb4ba6cc78ef9d7c320
oai_identifier_str oai:scielo:S0044-59672012000200005
network_acronym_str INPA-3
network_name_str Acta Amazonica
repository_id_str
spelling Impact of health legislation on the sale of anorectics in a city in the Amazon regionAnorectic drugsAmfepramoneFenproporexMazindolHealth surveillanceOBJECTIVES: The International Narcotics Control Board released its 2005 annual report, highlighting the Brazil population as one of the largest consumers of anorectics. In Brazil, the National Health Surveillance Agency issued the resolution RDC 58/2007 in order to control the prescription and sale of such drugs. In Belém, the biggest city in the Brazilian Amazon region, this resolution came into force in 2008, leading to inspections of drugstores and magistral pharmacies. The aim of this work was to evaluate the consumption of psychotropic anorectic drugs and the impact of RDC 58/2007 on the prescription and dispensing of anorectics in drugstores and magistral pharmacies in Belém. METHODOLOGY: A retrospective quantitative and descriptive study was conducted of records from the Municipal Department of Health Surveillance of Belém, for 2005 to 2008. The differences in findings were regarded significant when p < 0.05. RESULTS: A total of 1,641 balance sheets of drugstores and magistral pharmacies were analyzed. Amfepramone was the most dispensed medication, followed by fenproporex and mazindol. The highest consumption of anorectics occurred in magistral pharmacies. In 2008, there was a significant reduction in dispensing of anorectics, in drugstores as well as in magistral pharmacies. CONCLUSIONS: This study showed that there was a decrease in the dispensing of anorectics after RDC 58/2007 came into force, and that the magistral pharmacies dispensed more of these drugs. This resolution is a remarkable tool in health control, where it is of great benefit to public health and contributes substantially to the rational use of medicines in Brazil.Instituto Nacional de Pesquisas da Amazônia2012-06-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0044-59672012000200005Acta Amazonica v.42 n.2 2012reponame:Acta Amazonicainstname:Instituto Nacional de Pesquisas da Amazônia (INPA)instacron:INPA10.1590/S0044-59672012000200005info:eu-repo/semantics/openAccessCastro,Luana Valéria da SilvaFarias Junior,GilvoTeixeira,Francisco MartinsVieira,José Ricardo dos SantosMaia,Cristiane do Socorro Ferrazeng2012-03-06T00:00:00Zoai:scielo:S0044-59672012000200005Revistahttps://acta.inpa.gov.br/PUBhttps://old.scielo.br/oai/scielo-oai.phpacta@inpa.gov.br||acta@inpa.gov.br1809-43920044-5967opendoar:2012-03-06T00:00Acta Amazonica - Instituto Nacional de Pesquisas da Amazônia (INPA)false
dc.title.none.fl_str_mv Impact of health legislation on the sale of anorectics in a city in the Amazon region
title Impact of health legislation on the sale of anorectics in a city in the Amazon region
spellingShingle Impact of health legislation on the sale of anorectics in a city in the Amazon region
Castro,Luana Valéria da Silva
Anorectic drugs
Amfepramone
Fenproporex
Mazindol
Health surveillance
title_short Impact of health legislation on the sale of anorectics in a city in the Amazon region
title_full Impact of health legislation on the sale of anorectics in a city in the Amazon region
title_fullStr Impact of health legislation on the sale of anorectics in a city in the Amazon region
title_full_unstemmed Impact of health legislation on the sale of anorectics in a city in the Amazon region
title_sort Impact of health legislation on the sale of anorectics in a city in the Amazon region
author Castro,Luana Valéria da Silva
author_facet Castro,Luana Valéria da Silva
Farias Junior,Gilvo
Teixeira,Francisco Martins
Vieira,José Ricardo dos Santos
Maia,Cristiane do Socorro Ferraz
author_role author
author2 Farias Junior,Gilvo
Teixeira,Francisco Martins
Vieira,José Ricardo dos Santos
Maia,Cristiane do Socorro Ferraz
author2_role author
author
author
author
dc.contributor.author.fl_str_mv Castro,Luana Valéria da Silva
Farias Junior,Gilvo
Teixeira,Francisco Martins
Vieira,José Ricardo dos Santos
Maia,Cristiane do Socorro Ferraz
dc.subject.por.fl_str_mv Anorectic drugs
Amfepramone
Fenproporex
Mazindol
Health surveillance
topic Anorectic drugs
Amfepramone
Fenproporex
Mazindol
Health surveillance
description OBJECTIVES: The International Narcotics Control Board released its 2005 annual report, highlighting the Brazil population as one of the largest consumers of anorectics. In Brazil, the National Health Surveillance Agency issued the resolution RDC 58/2007 in order to control the prescription and sale of such drugs. In Belém, the biggest city in the Brazilian Amazon region, this resolution came into force in 2008, leading to inspections of drugstores and magistral pharmacies. The aim of this work was to evaluate the consumption of psychotropic anorectic drugs and the impact of RDC 58/2007 on the prescription and dispensing of anorectics in drugstores and magistral pharmacies in Belém. METHODOLOGY: A retrospective quantitative and descriptive study was conducted of records from the Municipal Department of Health Surveillance of Belém, for 2005 to 2008. The differences in findings were regarded significant when p < 0.05. RESULTS: A total of 1,641 balance sheets of drugstores and magistral pharmacies were analyzed. Amfepramone was the most dispensed medication, followed by fenproporex and mazindol. The highest consumption of anorectics occurred in magistral pharmacies. In 2008, there was a significant reduction in dispensing of anorectics, in drugstores as well as in magistral pharmacies. CONCLUSIONS: This study showed that there was a decrease in the dispensing of anorectics after RDC 58/2007 came into force, and that the magistral pharmacies dispensed more of these drugs. This resolution is a remarkable tool in health control, where it is of great benefit to public health and contributes substantially to the rational use of medicines in Brazil.
publishDate 2012
dc.date.none.fl_str_mv 2012-06-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0044-59672012000200005
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0044-59672012000200005
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/S0044-59672012000200005
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Instituto Nacional de Pesquisas da Amazônia
publisher.none.fl_str_mv Instituto Nacional de Pesquisas da Amazônia
dc.source.none.fl_str_mv Acta Amazonica v.42 n.2 2012
reponame:Acta Amazonica
instname:Instituto Nacional de Pesquisas da Amazônia (INPA)
instacron:INPA
instname_str Instituto Nacional de Pesquisas da Amazônia (INPA)
instacron_str INPA
institution INPA
reponame_str Acta Amazonica
collection Acta Amazonica
repository.name.fl_str_mv Acta Amazonica - Instituto Nacional de Pesquisas da Amazônia (INPA)
repository.mail.fl_str_mv acta@inpa.gov.br||acta@inpa.gov.br
_version_ 1752129839435874304